• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受透析治疗的慢性肾衰竭患者的叶酸状况

Folic acid status of patients with chronic renal failure maintained by dialysis.

作者信息

Hemmeloff Andersen K E

出版信息

Clin Nephrol. 1977 Dec;8(6):510-3.

PMID:598056
Abstract

Twenty-five uremic patients on chronic hemodialysis were followed over a period of 9 months with regard to hemoglobin, mean corpuscular volume and folate concentration in serum and erythrocytes. The daily dietary intake of folic acid was estimated at 80-90 microgram, and no folic acid supplements were given. None of the patients developed macrocytic anemia. At the end of the period all patients had a normal erythrocyte folate content. Serum folate was normal in 17 and below normal in 8 patients. These 8 patients were in a negative folate balance at the time of investigation. In 7 patients dialyzed with a RP VI dialyzer the maximum loss of folic acid was 75 microgram/dialysis, and in 6 patients on chronic intermittent peritoneal dialysis the maximum loss was 13 microgram/dialysis. Thus there is no need for oral folic acid supplementation in uremic patients on chronic dialysis provided that daily dietary intake of folic acid is adequate.

摘要

对25名接受慢性血液透析的尿毒症患者进行了为期9个月的随访,观察其血红蛋白、平均红细胞体积以及血清和红细胞中的叶酸浓度。估计每日膳食叶酸摄入量为80 - 90微克,且未给予叶酸补充剂。所有患者均未发生巨幼细胞贫血。在该阶段结束时,所有患者的红细胞叶酸含量均正常。17名患者的血清叶酸正常,8名患者低于正常水平。这8名患者在调查时叶酸处于负平衡状态。使用RP VI透析器进行透析的7名患者,叶酸最大丢失量为75微克/次透析;6名进行慢性间歇性腹膜透析的患者,叶酸最大丢失量为13微克/次透析。因此,只要每日膳食叶酸摄入量充足,慢性透析的尿毒症患者无需口服补充叶酸。

相似文献

1
Folic acid status of patients with chronic renal failure maintained by dialysis.接受透析治疗的慢性肾衰竭患者的叶酸状况
Clin Nephrol. 1977 Dec;8(6):510-3.
2
[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].[透析患者高同型半胱氨酸血症的治疗:叶酸还是高流量聚砜膜?]
Acta Med Croatica. 2006 Jun;60(3):201-8.
3
[Is it necessary to supplement with folic acid patients in chronic dialysis treated with erythropoietin?].[接受促红细胞生成素治疗的慢性透析患者是否需要补充叶酸?]
Rev Med Chil. 1993 Jan;121(1):30-5.
4
Effects of folate and zinc supplementation on patients undergoing chronic hemodialysis.
J Am Diet Assoc. 1992 May;92(5):574-9.
5
Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.终末期肾病患者高同型半胱氨酸血症对补充叶酸的反应。
Clin Nephrol. 1999 Feb;51(2):108-15.
6
Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy.
Clin Nephrol. 1992 Nov;38(5):290-2.
7
[Blood folates in chronic uremic patients in dialysis treatment].
Minerva Med. 1980 Oct 31;71(42):3073-86.
8
Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.叶酸缺乏会改变维持性透析患者对重组人促红细胞生成素的造血反应。
Nephrol Dial Transplant. 2006 Jan;21(1):133-7. doi: 10.1093/ndt/gfi086. Epub 2005 Sep 6.
9
[Vitamin B12 and folic acid in chronic kidney failure and after kidney transplantation].
Cas Lek Cesk. 1991 Jan 18;130(3):84-7.
10
[Hematologic changes in patients under long-term hemodialysis and hemofiltration treatment with special reference to serum concentrations of folic acid and vitamin B 12].[长期血液透析和血液滤过治疗患者的血液学变化,特别提及叶酸和维生素B12的血清浓度]
Schweiz Med Wochenschr. 1984 Jan 14;114(2):48-53.